COVID19

COVID19 Protection Supplies

FulCare: Home>Products>COVID19

COVID19 Antibody IgM/IgG Rapid Test

Time: 2020-02-08
Views: 587
Category: COVID19
Type: Protective Supplies
Product Details

The outbreak of the novel coronavirus (SARS-CoV-2) disease is now a pandemic and a serious public health crisis worldwide. There is an urgent need for the introduction of an accurate, easy, and rapid alternative test to identify potential infected individuals.


The Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19 was prepared by colloidal gold immunochromatography using anti-human IgM and anti-human IgG antibodies coated on nitrocellulose membranes and colloidal gold labeled SARS-CoV-2 S/N antigens and other reagents. When tested, the gold-labeled antigen will form a complex with the specific antibody in the sample. 


If there is a IgM or IgG antibody specific to the SARS-CoV-2 antigen in the sample, the antibody forms a complex with the gold-labeled antigen and moves forward along the test strip due to chromatography, and the solid-phase anti-human IgM or anti-human antibody in the detected line is captured to form a sandwich complex to condense the color. 


If it is a negative specimen, even if it can form a sandwich complex, it can not be captured as a specific antigen component in the detection area, so it does not develop color. Regardless of whether there is SARS- CoV-2 antibody in the sample, a colored strip will appear in the quality control area, as the internal control standard of whether the chromatography process is normal or not, and whether the reagent is invalid.

11.bmp

11.bmp

Advantages of the Product

1) Early discovery: positive IgM indicate early phase of infection

2) Whole spectrum: cover early, mid and late phase of disease, avoid missing

3) Efficiency: one test contain specific IgM and IgG antibodies, don’t need any other equipment,

and the result can be read in ten mins.

4) Safety: Individual test avoid cross-infection.


Overseas Registration List

  1. CE: registration in Germany

  2. UK: MHRA

  3. Peru: DIGEMID

  4. Singapore: HSA

  5. Malaysia: MDA

  6. Turkey: TSE

  7. Brazil: ANVISA

  8. Italy


Introduction of IgM and IgG Antibodies

12.bmp

1) IgM antibody: Appear on day 1-7 of an acute infection. Detection of IgM in blood indicates a recent infection. It can be used as early screening for SRAS- Cov-2 suspected population.

2) IgG antibody: In the mid to late stage of infection, B lymphocytes enter lymph node and transform into plasma cells and produce large amount of IgG. Detection of IgG indicate on-going or past infection, useful in the monitoring of progress of infection.


Intended Use and Applicable People

Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19 has been designed to be used for IN VITRO, is used fordetection of SARS-CoV-2 virus- specific IgM and IgG antibodies in human Whole blood/serum/plasma. It is suitable for auxiliary diagnosis of suspected patients with novel coronavirus disease.


Downloads

IgM-IgG Packing.pdf

IgM-IgG Product Brochure.pdf

IgM-IgG Product Clinical Trial Data.pdf

IgM-IgG Product IFU_1.pdf


Prev: N/A

Next: N/A